[Psychopharmacology of anxiety and depression: Historical aspects, current treatments and perspectives].
France. In Ann Pharm Fr, Nov 2015
Among the modulators of the glutamatergic axis, promising compounds include: (i) ionotropic regulators of NMDA receptors: esketamine, AVP-923 and AVP-786, CERC-301, rapastinel (Glyx-13), NRX-1074 developed for depression, rapastinel and bitopertine developed for obsessive compulsive disorder, (ii) metabotropic glutamate receptors modulators: decoglurant and basimglurant developed for depression and mavoglurant developed for obsessive compulsive disorder.
Anthrax prophylaxis: recent advances and future directions.
Salisbury, United Kingdom. In Front Microbiol, 2014
It describes the licensed acellular vaccines AVA and AVP and discusses the prospects for a next generation of recombinant sub-unit vaccines for anthrax, balancing the regulatory requirement and current drive for highly defined vaccines, against the risk of losing the "danger" signals required to induce protective immunity in the vaccinee.
Nephrogenic syndrome of inappropriate antidiuresis.
San Francisco, United States. In N Engl J Med, 2005
We describe two infants whose clinical and laboratory evaluations were consistent with the presence of SIADH, yet who had undetectable arginine vasopressin (AVP) levels.